Évaluation coût/bénéfice du traitement des lombosciatalgies post-opératoires par stimulation médullaire

Blond, S.; Buisset, N.; Hieu, P. Dam; Nǵuyen, Jean-Paul; Lazorthes, Y; Cantagrel, N.; Laugner, B.; Bellow, Francis; Djian, Marie-Christine; Husson, J. L.; Lapierre, F; Blanc, J.-L.

doi:10.1016/s0028-3770(04)98324-5

Cited by 19 publications

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A few studies have assessed the cost‐effectiveness balance of SCS, taking into account direct or indirect costs, 13,14,15 or both 16 . Economically, RTW status—thus decreasing indirect costs—is a critical variable analyzed by independent health technology assessment 17 .…”

Section: Introductionmentioning

confidence: 99%

“…10 Half of these patients are not satisfied with common treatments, 11 and spinal cord stimulation (SCS) therapy, consisting of an implantable pulse generator and an electrode placed epidurally over the thoracic spinal cord, can be an issue for them. 12 A few studies have assessed the cost-effectiveness balance of SCS, taking into account direct or indirect costs, 13,14,15 or both. 16 Economically, RTW status-thus decreasing indirect costs-is a critical variable analyzed by independent health technology assessment.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Spinal cord stimulation and return to work of patients with failed back surgery syndrome

et al. 2023

View full text Add to dashboard Cite

Objectives: Chronic pain has a substantial negative impact on work-related outcomes, which underlines the importance of interventions to reduce the burden. Spinal cord stimulation (SCS) efficiently relieves pain in specific chronic pain syndromes and is recommended for treating failed back surgery syndrome (FBSS) or post-surgical chronic back pain that is refractory to other treatments. To examine the impact of SCS in patients with FBSS on the return to work (RTW), we determined the RTW rate and the factors positively associated with the RTW. Materials and Methods: Among 106 patients with FBSS who benefitted from SCS at a single institution in France between September 1999 and March 2010, we retrospectively included 59 who had stopped work at the time of SCS because of disability or sick leave and evaluated the RTW (rate and predictors, estimating odds ratios [ORs] and 95% confidence intervals [CIs]). Results: The mean (SD) post-surgery follow-up for the 59 patients (34 men; mean [SD] age 46.9 [7.4] years) was 7.5 (3.6) years (range 5-15). The RTW rate was 30.5%, with a median [IQR] recovery time of 5.5 months [3-8.5]. RTW was improved with functional improvement evolution (OR 1.1, 95% CI [1.01-1.1], p = 0.02) and was reduced with unemployment > 3 years (OR 0.1, 95% CI [0.01-0.7], p = 0.02). Conclusions: Our protocol for SCS for patients with FBSS, including a strict selection of patients and a multidisciplinary approach, led to good results, especially for the RTW. RTW should be a therapeutic goal, directly affecting indirect costs related to FBSS. K E Y W O R D S failed back surgery syndrome, low back pain, return to work, spinal cord stimulation How to cite this article: Dauriac-Le Masson V, Gatt M-T, Chekroun C, Turak B, Djian MC. Spinal cord stimulation and return to work of patients with failed back surgery syndrome.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Spinal cord stimulation and return to work of patients with failed back surgery syndrome

et al. 2023

View full text Add to dashboard Cite

show abstract

Spinal cord stimulation for chronic refractory pain: Long‐term effectiveness and safety data from a multicentre registry

Brînzeu

Cuny

Fontaine

et al. 2019

European Journal of Pain

View full text Add to dashboard Cite

Background Spinal cord stimulation (SCS) is an established therapy for refractory neuropathic pain. To ascertain the balance between treatment benefits and risks, the French National Authority for Health requested a post‐market registry for real‐world evaluation of the long‐term effectiveness and safety of the therapy. Methods A total of 402 patients undergoing implantation with a Medtronic SCS device as either a primo‐implant (n = 264) or replacement implant (n = 138) were enrolled across 28 representative sites in France. Outcome measures at 2 years included pain intensity, satisfaction with treatment, improvement of pain relief and daily life activity, willingness to undergo the treatment again and use of pain treatments. A patient was considered a responder if, compared to baseline, predominant pain reduction was ≥50%. Results At the 2‐year follow‐up visit, predominant pain intensity for primo‐implant patients had decreased from baseline (p < 0.001), with responder rates of 55%, 36% and 67% for the lower limbs, back and upper limbs, respectively. Most patients acknowledged an improvement in pain relief (89%) and daily life activity (82%) were satisfied with treatment (91%) and willing to undergo the treatment again (93%). A significant decrease (p < 0.01) in the proportion of patients receiving pain treatment was observed for all drug and non‐drug treatments. Reported adverse events were in line with the literature. Pain intensity at 2 years was comparable for patients in the replacement group, supporting the long‐term stability and effectiveness of SCS. Conclusion Real‐world evaluation of the use of spinal cord stimulation under the recommendations of the French Health Authority shows that two years after the first implantation of an SCS device close to 60% of the patients retain a significant pain reduction and 74% show improvement in pain scores [of at least 30%] with significant decreases in drug and non‐drug pain treatments. Significance This observational, prospective study in a real‐life setting followed a large cohort of patients suffering from chronic pain and implanted with SCS devices in France. The study assessed the long‐term effectiveness and safety of SCS therapy in a representative sample of implanting sites in France.

show abstract

« FBSS » et stimulation médullaire : résultats à long terme dans la littérature

Abeloos

Chaskis

2014

Chirurgie De La Douleur

View full text Add to dashboard Cite

Évaluation coût/bénéfice du traitement des lombosciatalgies post-opératoires par stimulation médullaire

Cited by 19 publications

References 29 publications

Spinal cord stimulation and return to work of patients with failed back surgery syndrome

Spinal cord stimulation and return to work of patients with failed back surgery syndrome

Spinal cord stimulation for chronic refractory pain: Long‐term effectiveness and safety data from a multicentre registry

« FBSS » et stimulation médullaire : résultats à long terme dans la littérature

Contact Info

Product

Resources

About